Device type · OVB
Hydrogel Spacer
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OVB
Radiology
Device class
Class II
FDA decisions since 2015
8
510(k), De Novo and PMA
Adverse event reports
364
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Hydrogel Spacer
- Product code
- OVB
- Device class
- Class II
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5725
- Specialty
- Radiology & Imaging
- FDA record
- Classification database entry for OVB
Latest FDA decisions
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
K260119 · Decided Feb 10, 2026 · 27 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
K222972 · Decided Aug 25, 2023 · 332 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
- Barrigel Injectable Gel510(k)
K220641 · Decided May 26, 2022 · 83 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
- SpaceOAR System510(k)
K202224 · Decided Aug 28, 2020 · 21 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
- SpaceOAR Vue Hydrogel510(k)
K182971 · Decided Jul 19, 2019 · 266 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
- SpaceOAR System510(k)
K181465 · Decided Jun 25, 2018 · 21 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
- SpaceOAR SystemNew device typeDe Novo
DEN140030 · Decided Apr 1, 2015 · 182 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
Reports received
364
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
232
64% of reports
Injury reports
130
36% of reports
Death reports
2
0.5% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 20 | 10 | 0 | 0 |
| Jan 24 | 14 | 8 | 0 | 0 |
| Feb 24 | 19 | 11 | 0 | 0 |
| Mar 24 | 19 | 8 | 0 | 0 |
| Apr 24 | 18 | 6 | 1 | 0 |
| May 24 | 15 | 10 | 0 | 0 |
| Jun 24 | 18 | 13 | 0 | 0 |
| Jul 24 | 22 | 7 | 0 | 0 |
| Aug 24 | 22 | 6 | 0 | 0 |
| Sep 24 | 15 | 9 | 0 | 0 |
| Oct 24 | 20 | 12 | 0 | 0 |
| Nov 24 | 6 | 14 | 0 | 0 |
| Dec 24 | 19 | 17 | 0 | 0 |
| Jan 25 | 10 | 8 | 0 | 0 |
| Feb 25 | 19 | 11 | 0 | 0 |
| Mar 25 | 10 | 4 | 0 | 0 |
| Apr 25 | 17 | 11 | 0 | 0 |
| May 25 | 16 | 13 | 0 | 0 |
| Jun 25 | 15 | 9 | 0 | 0 |
| Jul 25 | 21 | 12 | 0 | 0 |
| Aug 25 | 14 | 12 | 0 | 0 |
| Sep 25 | 26 | 12 | 1 | 0 |
| Oct 25 | 25 | 14 | 0 | 0 |
| Nov 25 | 26 | 6 | 0 | 0 |
| Dec 25 | 10 | 18 | 0 | 0 |
| Jan 26 | 10 | 14 | 0 | 0 |
| Feb 26 | 15 | 5 | 0 | 0 |
| Mar 26 | 30 | 16 | 0 | 0 |
| Apr 26 | 21 | 9 | 0 | 0 |
| May 26 | 20 | 10 | 1 | 0 |
| Jun 26 | 18 | 6 | 0 | 0 |
| Jul 26 | 21 | 9 | 0 | 0 |
| Aug 26 | 26 | 9 | 1 | 0 |
| Sep 26 | 21 | 16 | 0 | 0 |
| Oct 26 | 14 | 12 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Malposition of Device228
- Adverse Event Without Identified Device or Use Problem80
- Material Integrity Problem29
- Migration24
- Positioning Problem16
- No Apparent Adverse Event14
- Obstruction of Flow9
- Use of Device Problem6
- Device Contamination with Chemical or Other Material4
- Device Ingredient or Reagent Problem3
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions193
- Pain42
- Abscess34
- Hemorrhage/Blood Loss/Bleeding34
- Unspecified Infection29
- Urinary Retention28
- Discomfort26
- Inflammation24
- Ulcer23
- Fistula19
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1002-2022 · Started Feb 24, 2022
Reason given: Users need to be aware that embolism is a possible adverse event associated with hydrogel misplacements. Updated IFU provides new procedural instructions, warnings and precautions that describe steps to verify correct placement of the hydrogel following implantation, as well as technique recommendations for the proper...
Cause as FDA categorized it: Labeling design
Z-1003-2022 · Started Feb 24, 2022
Reason given: Users need to be aware that embolism is a possible adverse event associated with hydrogel misplacements. Updated IFU provides new procedural instructions, warnings and precautions that describe steps to verify correct placement of the hydrogel following implantation, as well as technique recommendations for the proper...
Cause as FDA categorized it: Labeling design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.